Safety of cardiac catheterization at a center specializing in the care of patients with pulmonary arterial hypertension

Pulmonary Circulation

Volumn 3, Issue 4, 2013, Pages 831-839

  Zuckerman, Warren A ^a   Turner, Mariel E ^a   Kerstein, Jason ^a   Torres, Alejandro ^a   Vincent, Julie A ^a   Krishnan, Usha ^a   Kerstein, Diane ^a   Rosenzweig, Erika B ^a  

^a Department of Medicine   (United States)

Author keywords

Adults; Cardiac catheterization; Pediatrics; Pulmonary arterial hypertension; Safety

Indexed keywords

EID: 84929856190     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.1086/674752     Document Type: Article

References (18)

1. D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991;115: 343-349.
2. Barst RJ, Maislin G, Fishman AP. Vasodilator therapy for primary pulmonary hypertension in children. Circulation 1999;99:1197-1208.
3. Barst RJ, McGoon MD, Elliott CG, Foreman AJ, Miller DP, Ivy DD. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and longterm pulmonary arterial hypertension disease management. Circulation 2012;125:113-122.
4. Benza RL, Miller DP, Barst RJ, Badesch DB, Frost AE, McGoon MD. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL registry. Chest 2012;142:448-456.
5. McLaughlin VV, Badesch DB, Delcroix M, et al. End points and clinical trial design in pulmonary arterial hypertension. J Am Coll Cardiol 2009;54:S97-S107.
6. Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54:S55-S66.
7. Clabby ML, Canter CE, Moller JH, Bridges ND. Hemodynamic data and survival in children with pulmonary hypertension. J Am Coll Cardiol 1997;30:554-560.
8. Kawut SM, Horn EM, Berekashvili KK, et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 2005;95:199-203.
9. Bergersen L, Marshall A, Gauvreau K, et al. Adverse event rates in congenital cardiac catheterization—a multi-center experience. Catheter Cardiovasc Interv 2010;75:389-400.
10. Learn CP, Holzer RJ, Daniels CJ, et al. Adverse events rates and risk factors in adults undergoing cardiac catheterization at pediatric hospitals-results from the C3PO. Catheter Cardiovasc Interv 2013;81:997-1005.
11. Hofmann LV, Lee DS, Gupta A, et al. Safety and hemodynamic effects of pulmonary angiography in patients with pulmonary hypertension: 10-year single-center experience. AJR Am J Roentgenol 2004;183:779-786.
12. Taylor CJ, Derrick G, McEwan A, Haworth SG, Sury MR. Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension. Br J Anaesth 2007;98: 657-661.
13. Hill KD, Lim DS, Everett AD, Ivy DD, Moore JD. Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry. Catheter Cardiovasc Interv 2010;76:865-873.
14. Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006;48:2546-2552.
15. LaFarge CG, Miettinen OS. The estimation of oxygen consumption. Cardiovasc Res 1970;4:23-30.
16. Bergersen L, Gauvreau K, Jenkins KJ, Lock JE. Adverse event rates in congenital cardiac catheterization: a new understanding of risks. Congenit Heart Dis 2008;3:90-105.
17. Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984;70:580-587.
18. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987;107:216-223.